Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm
Traditionally, patients with type 2 diabetes have been stratified according to cardiovascular (CV) risk to requiring either primary prevention (those without atherosclerotic CV disease) or secondary prevention (those with atherosclerotic CV disease in any of the vascular beds). However, this classif...
Main Authors: | Xavier Garcia-Moll, Vivencio Barrios, Josep Franch-Nadal |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2021-08-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/moving-from-the-stratification-of-primary-and-secondary-prevention-of-cardiovascular-risk-in-diabetes-towards-a-continuum-of-risk:-need-for-a-new-paradigm |
Similar Items
-
Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
by: Alberto Aimo, et al.
Published: (2020-01-01) -
Degree of Agreement between Cardiovascular Risk Stratification Tools
by: Guilherme Thomé Garcia, et al. -
Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction
by: Naufal Zagidullin, et al.
Published: (2020-02-01) -
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
by: Mart A.F.J. van de Laar, et al.
Published: (2010-07-01) -
Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low- and moderate-risk patients: data from 10-year follow-up
by: M. D. Smirnova, et al.
Published: (2021-07-01)